Your browser doesn't support javascript.
loading
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers.
Roberts, Kathryn G; Smith, Amanda M; McDougall, Fiona; Carpenter, Helen; Horan, Martin; Neviani, Paolo; Powell, Jason A; Thomas, Daniel; Guthridge, Mark A; Perrotti, Danilo; Sim, Alistair T R; Ashman, Leonie K; Verrills, Nicole M.
Affiliation
  • Roberts KG; School of Biomedical Sciences, University of Newcastle, Callaghan, New South Wales, Australia.
Cancer Res ; 70(13): 5438-47, 2010 Jul 01.
Article in En | MEDLINE | ID: mdl-20551067

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proto-Oncogene Proteins c-kit / Protein Phosphatase 2 Limits: Aged / Animals / Female / Humans / Male Language: En Journal: Cancer Res Year: 2010 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Proto-Oncogene Proteins c-kit / Protein Phosphatase 2 Limits: Aged / Animals / Female / Humans / Male Language: En Journal: Cancer Res Year: 2010 Document type: Article Affiliation country: Australia